Company Filing History:
Years Active: 2002
Title: Dieter Riesenberg: Innovator in Molecular Probes and Recombinant Proteins
Introduction
Dieter Riesenberg is a notable inventor based in Jena, Germany. He has made significant contributions to the fields of molecular probes and recombinant protein production. With a total of 2 patents, his work focuses on innovative approaches to targeting chemotherapeutics and enhancing protein yield.
Latest Patents
Riesenberg's latest patents include groundbreaking inventions in the realm of molecular probes for targeting cell density-indicating compounds. This invention provides a new method for directing chemotherapeutics to focal bacterial infections characterized by high bacterial densities. The invention utilizes molecular modules that combine targeting components with chemotherapeutical agents for photodynamic antimicrobial chemotherapy (PACT). Another significant patent involves a fed-batch fermentation process for the efficient production of recombinant proteins, particularly antibody fragments, in E. coli. This process allows for high cell density growth and maximizes the yield of recombinant products.
Career Highlights
Throughout his career, Riesenberg has worked with prominent companies such as Merck Patent Gesellschaft and Biolitec AG. His expertise in molecular biology and biotechnology has led to advancements in both therapeutic and industrial applications.
Collaborations
Riesenberg has collaborated with notable colleagues, including Wolfgang Strittmatter and Siegfried Matzku. These partnerships have contributed to the development of innovative solutions in his field.
Conclusion
Dieter Riesenberg's contributions to molecular probes and recombinant protein production highlight his role as a leading inventor in biotechnology. His patents reflect a commitment to advancing medical and scientific knowledge through innovative solutions.